CP3 Study Team

A multi-disciplinary and institutional team of investigators.

Increasing the lifespan and health of individuals living with psoriatic disease through personalized cardiovascular disease prevention care.

The CP3 study is funded by the National Psoriasis Foundation's Psoriasis Prevention Initiative through Dr. Joel Gelfand's project "Prevention of cardiovascular disease and mortality in patients with psoriasis or psoriatic arthritis (CP3): Translating guidelines of care to better outcomes for patients with psoriatic disease."

Principal Investigator

Joel Gelfand, M.D., MSCE

James J. Leyden Professor of Dermatology & Epidemiology, Director Center for Clinical Sciences in Dermatology, Director Psoriasis & Phototherapy Treatment Center at University of Pennsylvania Perelman School of Medicine

Read bio

Co-Principal Investigators

April Armstrong, M.D., MPH

Professor and Chief of Dermatology at University of California Los Angeles

Read bio

John Barbieri, M.D., MBA

Assistant Professor of Dermatology at Harvard Medical School and Director of the Advanced Acne Therapeutics Clinic

Read bio

Rinad Beidas, Ph.D.

Department Chair and Ralph Seal Paffenbarger Professor of Medical Social Sciences at Northwestern University Feinberg School of Medicine

Read bio

Nehal Mehta, M.D., MSCE

Cardiovascular Inflammatory Specialist, Clinical Professor of Medicine at George Washington University

Read bio

Alexis Ogdie, M.D., MSCE

Associate Professor of Medicine (Rheumatology) and Epidemiology, Director of the Center for Clinical Epidemiology and Biostatistics at the University of Pennsylvania

Read bio

Join CP3

If you are a dermatologist and would like to learn more about participating in the CP3 Study, please contact us at cp3study@pennmedicine.upenn.edu.